PLUS1
0.568
0.0101 (1.81%)
0.0101 (1.81%)
Upgrade to Real-Time
Afterhours (Closed)
Low
0.5381
High
2.63
Best deals to access real time data! |
|
CHART Trader
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Small Cap Basic
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| AzurRx BioPharma Inc | AZRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| 0.0101 | 1.81% | 0.568 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 0.5411 | 0.5406 | 0.5586 | 0.5438 | 0.5579 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 0.5402 | 0.568 | 0.0278 | - | - |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 2,106 | 992,974 | $ 0.5514466 | $ 547,572 | - | 0.5381 - 2.63 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:47:53 | formt | 500 | $ 0.568 | USD |
Period:
Draw Mode:
AzurRx BioPharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 47.03M | 82.81M | 81.97M | $ - | $ - | -1.15 | -0.40 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | - | - | 1.70% |
AzurRx BioPharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AZRX Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 0.5457 | 0.6369 | 0.5381 | 0.5720457 | 5,224,371 | 0.0223 | 4.09% |
| 1 Month | 0.80 | 0.83 | 0.5381 | 0.6275449 | 2,083,070 | -0.232 | -29.0% |
| 3 Months | 0.807 | 0.97 | 0.5381 | 0.7238482 | 1,307,134 | -0.239 | -29.62% |
| 6 Months | 1.54 | 2.05 | 0.5381 | 1.21 | 2,946,282 | -0.972 | -63.12% |
| 1 Year | 0.9856 | 2.63 | 0.5381 | 1.38 | 3,092,068 | -0.4176 | -42.37% |
| 3 Years | 2.26 | 3.75 | 0.370868 | 1.36 | 1,188,422 | -1.69 | -74.87% |
| 5 Years | 5.06 | 5.60 | 0.370868 | 1.40 | 762,525 | -4.49 | -88.77% |
AzurRx BioPharma Description
| AzurRx BioPharma Inc is a development stage biopharmaceutical company. The company is focused on the development of recombinant proteins for the treatment of gastrointestinal diseases and microbiome-related conditions. Its lead product candidate is MS1819, a yeast-derived recombinant lipase for exocrine pancreatic insufficiency (EPI) associated with cystic fibrosis (CF) and chronic pancreatitis (CP). |
